BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 38002980)

  • 1. Association between NTRK2 Polymorphisms, Hippocampal Volumes and Treatment Resistance in Major Depressive Disorder.
    Paolini M; Fortaner-Uyà L; Lorenzi C; Spadini S; Maccario M; Zanardi R; Colombo C; Poletti S; Benedetti F
    Genes (Basel); 2023 Nov; 14(11):. PubMed ID: 38002980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible associations of NTRK2 polymorphisms with antidepressant treatment outcome: findings from an extended tag SNP approach.
    Hennings JM; Kohli MA; Czamara D; Giese M; Eckert A; Wolf C; Heck A; Domschke K; Arolt V; Baune BT; Horstmann S; Brückl T; Klengel T; Menke A; Müller-Myhsok B; Ising M; Uhr M; Lucae S
    PLoS One; 2013; 8(6):e64947. PubMed ID: 23750220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project.
    Perroud N; Aitchison KJ; Uher R; Smith R; Huezo-Diaz P; Marusic A; Maier W; Mors O; Placentino A; Henigsberg N; Rietschel M; Hauser J; Souery D; Kapelski P; Bonvicini C; Zobel A; Jorgensen L; Petrovic A; Kalember P; Schulze TG; Gupta B; Gray J; Lewis CM; Farmer AE; McGuffin P; Craig I
    Neuropsychopharmacology; 2009 Nov; 34(12):2517-28. PubMed ID: 19641488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antidepressant efficacy of subanesthetic-dose ketamine does not correlate with baseline subcortical volumes in a replication sample with major depressive disorder.
    Niciu MJ; Iadarola ND; Banerjee D; Luckenbaugh DA; Park M; Lener M; Park L; Ionescu DF; Ballard ED; Brutsche NE; Akula N; McMahon FJ; Machado-Vieira R; Nugent AC; Zarate CA
    J Psychopharmacol; 2017 Dec; 31(12):1570-1577. PubMed ID: 29039254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains.
    Dunham JS; Deakin JF; Miyajima F; Payton A; Toro CT
    J Psychiatr Res; 2009 Sep; 43(14):1175-84. PubMed ID: 19376528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene-based analysis of genes related to neurotrophic pathway suggests association of BDNF and VEGFA with antidepressant treatment-response in depressed patients.
    Kao CF; Liu YL; Yu YW; Yang AC; Lin E; Kuo PH; Tsai SJ
    Sci Rep; 2018 May; 8(1):6983. PubMed ID: 29725086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal volumes and the brain-derived neurotrophic factor val66met polymorphism in geriatric major depression.
    Kanellopoulos D; Gunning FM; Morimoto SS; Hoptman MJ; Murphy CF; Kelly RE; Glatt C; Lim KO; Alexopoulos GS
    Am J Geriatr Psychiatry; 2011 Jan; 19(1):13-22. PubMed ID: 21218562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal Hippocampal Subfields May Be Potential Predictors of Worse Early Response to Antidepressant Treatment in Drug-Naïve Patients With Major Depressive Disorder.
    Hu X; Zhang L; Hu X; Lu L; Tang S; Li H; Bu X; Gong Q; Huang X
    J Magn Reson Imaging; 2019 Jun; 49(6):1760-1768. PubMed ID: 30295348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence variations of ABCB1, SLC6A2, SLC6A3, SLC6A4, CREB1, CRHR1 and NTRK2: association with major depression and antidepressant response in Mexican-Americans.
    Dong C; Wong ML; Licinio J
    Mol Psychiatry; 2009 Dec; 14(12):1105-18. PubMed ID: 19844206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association study of a brain-derived neurotrophic-factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response.
    Tsai SJ; Cheng CY; Yu YW; Chen TJ; Hong CJ
    Am J Med Genet B Neuropsychiatr Genet; 2003 Nov; 123B(1):19-22. PubMed ID: 14582140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Impact of
    Santos M; Lima L; Carvalho S; Mota-Pereira J; Pimentel P; Maia D; Correia D; Barroso MF; Gomes S; Cruz A; Medeiros R
    Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No impact of eight NTRK2 genetic polymorphisms on 6-month antidepressant efficacy in depressed patients.
    Deflesselle E; Verstuyft C; Petit AC; Hardy P; David DJ; Falissard B; Fève B; Rigal L; Becquemont L; Corruble E; Colle R
    Pharmacogenomics; 2017 Mar; 18(4):349-357. PubMed ID: 28244805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurotrophic tyrosine kinase polymorphism impacts white matter connections in patients with major depressive disorder.
    Murphy ML; Carballedo A; Fagan AJ; Morris D; Fahey C; Meaney J; Frodl T
    Biol Psychiatry; 2012 Oct; 72(8):663-70. PubMed ID: 22609366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene-gene interactions of the brain-derived neurotrophic-factor and neurotrophic tyrosine kinase receptor 2 genes in geriatric depression.
    Lin E; Hong CJ; Hwang JP; Liou YJ; Yang CH; Cheng D; Tsai SJ
    Rejuvenation Res; 2009 Dec; 12(6):387-93. PubMed ID: 20014955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of genetic variants in the neurotrophic receptor-encoding gene NTRK2 and a lifetime history of suicide attempts in depressed patients.
    Kohli MA; Salyakina D; Pfennig A; Lucae S; Horstmann S; Menke A; Kloiber S; Hennings J; Bradley BB; Ressler KJ; Uhr M; Müller-Myhsok B; Holsboer F; Binder EB
    Arch Gen Psychiatry; 2010 Apr; 67(4):348-59. PubMed ID: 20124106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BDNF-TrkB pathway mediates antidepressant-like roles of H
    Liu HY; Wei HJ; Wu L; Liu SM; Tang YY; Zou W; Wang CY; Zhang P; Tang XQ
    Clin Exp Pharmacol Physiol; 2020 Feb; 47(2):302-312. PubMed ID: 31660632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of monoamine-related gene polymorphisms on hippocampal volume in treatment-resistant depression.
    Phillips JL; Batten LA; Tremblay P; Aldosary F; Du L; Blier P
    Acta Neuropsychiatr; 2015 Dec; 27(6):353-61. PubMed ID: 25990886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of the brain-derived neurotrophic factor Val66Met polymorphism with reduced hippocampal volumes in major depression.
    Frodl T; Schüle C; Schmitt G; Born C; Baghai T; Zill P; Bottlender R; Rupprecht R; Bondy B; Reiser M; Möller HJ; Meisenzahl EM
    Arch Gen Psychiatry; 2007 Apr; 64(4):410-6. PubMed ID: 17404118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brain-derived neurotrophic factor gene polymorphisms: influence on treatment response phenotypes of major depressive disorder.
    Kocabas NA; Antonijevic I; Faghel C; Forray C; Kasper S; Lecrubier Y; Linotte S; Massat I; Mendlewicz J; Noro M; Montgomery S; Oswald P; Snyder L; Zohar J; Souery D
    Int Clin Psychopharmacol; 2011 Jan; 26(1):1-10. PubMed ID: 21188787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antidepressant-like effects of Chaihu Shugan San: Dependent on the hippocampal BDNF-TrkB-ERK/Akt signaling activation in perimenopausal depression-like rats.
    Chen XQ; Li CF; Chen SJ; Liang WN; Wang M; Wang SS; Dong SQ; Yi LT; Li CD
    Biomed Pharmacother; 2018 Sep; 105():45-52. PubMed ID: 29843044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.